公开(公告)号：US20240189375A1

公开(公告)日：2024-06-13

申请号：US18554492

申请日：2022-04-13

申请人： Philip Morris Products S.A.

发明人： Julia HOENG ,  Marco VAN DER TOORN ,  Kasper RENGGLI ,  Letizia ASTROLOGO

IPC分类号： A61K36/05 ,  A61P31/14

CPC分类号： A61K36/05 ,  A61P31/14

摘要： A composition is provided, including eukaryotic microalgae or an extract thereof for treatment of a viral disease such as coronavirus, and for use as an inhibitor of the binding of Spike protein receptor binding domain (RBD) to Angiotensin-Converting Enzyme 2 (ACE2). A compound derivable from the eukaryotic microalgae is also provided for treatment of a viral disease. A composition is also provided, including prokaryotic microalgae or an extract thereof for treatment of a viral disease.

公开(公告)号：US20240131097A1

公开(公告)日：2024-04-25

申请号：US18494658

申请日：2023-10-24

申请人： University of Florida Research Foundation, Incorporated

发明人： Hendrik Luesch ,  Michelle S. Bousquet

IPC分类号： A61K36/05 ,  A23L33/105 ,  A61K8/34 ,  A61K8/49 ,  A61K31/055 ,  A61K31/085 ,  A61K31/352 ,  A61P29/00

CPC分类号： A61K36/05 ,  A23L33/105 ,  A61K8/347 ,  A61K8/498 ,  A61K31/055 ,  A61K31/085 ,  A61K31/352 ,  A61P29/00 ,  A61K2236/33 ,  A61K2236/53

摘要： The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.

公开(公告)号：US20240082326A1

公开(公告)日：2024-03-14

申请号：US18368888

申请日：2023-09-15

申请人： Macularity, Inc.

发明人： Connor McAulay

IPC分类号： A61K35/748 ,  A61K31/336 ,  A61K36/05 ,  A61K36/45

CPC分类号： A61K35/748 ,  A61K31/336 ,  A61K36/05 ,  A61K36/45

摘要： The present application discloses a method for enhancement of immune system functions in a subject. The method involves providing the subject with a spirulina or a spirulina-based formulation obtained from Arthrospira genus and/or Limnospira genus. This administration would merely depend upon the dosage amount and administration schedule thereof to the subject. For example, dosage amount, gap between doses, etc.

公开(公告)号：US20240076606A1

公开(公告)日：2024-03-07

申请号：US18273584

申请日：2022-01-18

申请人： ASK LABS

发明人： Hee Sik Kim ,  Yong Jae Lee ,  Su Bin Park

IPC分类号： C12N1/12 ,  A61K36/05 ,  C12P23/00

CPC分类号： C12N1/125 ,  A61K36/05 ,  C12P23/00 ,  C12R2001/89

摘要： The present invention relates to HS-LZ microalgae of the genus Chlorella (Chlorella sp. HS-LZ), which are novel microalgae characterized by being able to produce zeaxanthin and lutein, and uses thereof.

公开(公告)号：US20240016880A1

公开(公告)日：2024-01-18

申请号：US17898223

申请日：2022-08-29

申请人： Alastin Skincare, Inc.

发明人： John A. GARRUTO ,  Alan David WIDGEROW

IPC分类号： A61K38/08 ,  A61K8/58 ,  A61K31/01 ,  A61K31/047 ,  A61K31/231 ,  A61K31/47 ,  A61K31/685 ,  A61K31/695 ,  A61K31/74 ,  A61K8/26 ,  A61K8/37 ,  A61K8/41 ,  A61K8/42 ,  A61K8/49 ,  A61K8/55 ,  A61K8/60 ,  A61K8/64 ,  A61K8/891 ,  A61K8/894 ,  A61K8/97 ,  A61K9/00 ,  A61K31/16 ,  A61K31/353 ,  A61K31/7048 ,  A61K36/05 ,  A61K36/28 ,  A61K38/06 ,  A61K47/14 ,  A61K47/18 ,  A61K47/22 ,  A61K47/24 ,  A61K47/34 ,  A61Q19/00 ,  A61Q19/08

CPC分类号： A61K38/08 ,  A61K8/585 ,  A61K31/01 ,  A61K31/047 ,  A61K31/231 ,  A61K31/47 ,  A61K31/685 ,  A61K31/695 ,  A61K31/74 ,  A61K8/26 ,  A61K8/37 ,  A61K8/416 ,  A61K8/42 ,  A61K8/4973 ,  A61K8/498 ,  A61K8/553 ,  A61K8/602 ,  A61K8/64 ,  A61K8/891 ,  A61K8/894 ,  A61K8/97 ,  A61K9/0014 ,  A61K31/16 ,  A61K31/353 ,  A61K31/7048 ,  A61K36/05 ,  A61K36/28 ,  A61K38/06 ,  A61K47/14 ,  A61K47/186 ,  A61K47/22 ,  A61K47/24 ,  A61K47/34 ,  A61Q19/00 ,  A61Q19/08 ,  A61K2800/5922 ,  A61K2800/594 ,  A61K2800/75 ,  A61K2800/884 ,  A61K2300/00

摘要： Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

公开(公告)号：US11786570B2

公开(公告)日：2023-10-17

申请号：US16976037

申请日：2019-02-27

申请人： SYMRISE AG

发明人： Martina Herrmann ,  Sandra Gaebler ,  Dominik Stuhlmann ,  Ann-Christin Weseloh

IPC分类号： A61K36/05 ,  A61K8/9722 ,  A61K8/60 ,  A61K8/67 ,  A61K31/455 ,  A61K47/26 ,  A61K47/40

CPC分类号： A61K36/05 ,  A61K8/60 ,  A61K8/675 ,  A61K8/9722 ,  A61K31/455 ,  A61K47/26 ,  A61K47/40

摘要： The present invention discloses a composition comprising sugar alcohols or a combination of sugar alcohols and a Tetraselmis extract or either of the former together with niacinamide for treating or preventing dysfunctions of the human hair or skin or as a skin or hair care product.

公开(公告)号：US20190038709A1

公开(公告)日：2019-02-07

申请号：US16073867

申请日：2017-01-20

申请人： Shandong Zhonghai Pharmaceutical Co., Ltd.

发明人： Baozhen XU ,  Qian CHENG ,  Long CHENG

IPC分类号： A61K38/16 ,  A61K31/715 ,  A61K31/7012 ,  A61K31/4025 ,  A61K36/05 ,  A61K36/04 ,  A61K36/02 ,  A61K36/03 ,  A61K36/48 ,  A61K36/748 ,  A61P9/00

CPC分类号： A61K38/168 ,  A61K31/4025 ,  A61K31/7012 ,  A61K31/715 ,  A61K36/02 ,  A61K36/03 ,  A61K36/04 ,  A61K36/05 ,  A61K36/315 ,  A61K36/48 ,  A61K36/748 ,  A61K38/02 ,  A61K45/06 ,  A61P9/00 ,  A61K2300/00

摘要： A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.

公开(公告)号：US10034906B2

公开(公告)日：2018-07-31

申请号：US15245552

申请日：2016-08-24

申请人： MicroA AS

发明人： Charles Daniel Bavington ,  Claire Moss

IPC分类号： A61K36/05 ,  A61K8/9706 ,  A61K31/737 ,  A61K9/06 ,  A61K39/39 ,  A61K8/04 ,  A23L33/125 ,  A61Q19/00 ,  C12P19/04 ,  C08B37/00

CPC分类号： A61K36/05 ,  A23L33/125 ,  A23V2002/00 ,  A61K8/042 ,  A61K8/9706 ,  A61K9/06 ,  A61K31/737 ,  A61K39/39 ,  A61K2800/10 ,  A61K2800/805 ,  A61Q19/00 ,  C08B37/006 ,  C12P19/04

摘要： There is provided a composition comprising a polysaccharide obtainable from the microalgae, Prasinococcus capsulatus and strains related to P. capsulatus for use in the treatment of disorders of the immune system, for example in psoriasis and dermatological conditions, internal immune system disorders, in particular gut inflammatory conditions and respiratory conditions. Further, there is provided derivatives of a polysaccharide obtainable from the microalgae, Prasinococcus capsulatus or an algal strain related to P. capsulatus and the use of such derivatives in the treatment of disorders of the immune system.

公开(公告)号：US09999631B2

公开(公告)日：2018-06-19

申请号：US15194957

申请日：2016-06-28

申请人： U.S. NUTRACEUTICALS, LLC

发明人： John A. Minatelli ,  W. Stephen Hill ,  Rudi E. Moerck

IPC分类号： A61K31/728 ,  A61K31/122 ,  A61K36/9066 ,  A61K45/06 ,  A61K31/202 ,  A61K31/685 ,  A61K31/7028 ,  A61K36/05 ,  A61K36/185 ,  A61K36/324 ,  A61K36/74 ,  A61K9/48 ,  A61K31/7008 ,  A61K35/60 ,  A23L33/115 ,  A23L33/12 ,  A23L33/10 ,  A61K9/00 ,  A61K31/726 ,  A61K33/22 ,  A61K35/32 ,  A61K38/39

CPC分类号： A61K31/728 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/4858 ,  A61K31/122 ,  A61K31/202 ,  A61K31/685 ,  A61K31/7008 ,  A61K31/7028 ,  A61K31/726 ,  A61K33/22 ,  A61K35/32 ,  A61K35/60 ,  A61K35/612 ,  A61K36/05 ,  A61K36/185 ,  A61K36/324 ,  A61K36/74 ,  A61K36/9066 ,  A61K38/39 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2250/1842 ,  A23V2250/187 ,  A23V2250/1882

摘要： A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form.

公开(公告)号：US09974756B2

公开(公告)日：2018-05-22

申请号：US15271506

申请日：2016-09-21

申请人： U.S. NUTRACEUTICALS, LLC

发明人： John A. Minatelli ,  W. Stephen Hill ,  Rudi E. Moerck

IPC分类号： A01N31/04 ,  A61K31/122 ,  A61K31/728 ,  A61K31/661 ,  A61K31/6615 ,  A61K36/9066 ,  A61K45/06 ,  A61K31/202 ,  A61K31/685 ,  A61K31/7028 ,  A61K36/05 ,  A61K36/185 ,  A61K36/324 ,  A61K36/74 ,  A61K9/48 ,  A61K35/60 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A61K9/00 ,  A61K36/02 ,  A61K36/535

CPC分类号： A61K31/122 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/48 ,  A61K9/4858 ,  A61K31/202 ,  A61K31/661 ,  A61K31/6615 ,  A61K31/685 ,  A61K31/7028 ,  A61K31/728 ,  A61K35/60 ,  A61K36/02 ,  A61K36/05 ,  A61K36/185 ,  A61K36/324 ,  A61K36/535 ,  A61K36/74 ,  A61K36/9066 ,  A61K45/06 ,  A61K2236/10 ,  A61K2236/13 ,  A61K2236/33 ,  A61K2236/35 ,  A61K2236/53 ,  A61K2300/00 ,  A61K35/612 ,  A23V2200/316 ,  A23V2250/1842 ,  A23V2250/187 ,  A23V2250/1882

摘要： A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.